BRIEF-Cipher Pharmaceuticals announces Canadian launch of Beteflam

Tue Apr 5, 2016 4:22pm EDT
 
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article
[-] Text [+]

April 5 (Reuters) - Cipher Pharmaceuticals Inc

* Cipher pharmaceuticals announces canadian launch of beteflam

* Commonly reported adverse drug reactions that occurred in patients using beteflam were skin and subcutaneous tissue disorders

* Expect to continue growth with six products targeted for canadian market in 2016 and eight in 2017 Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)